Historically, medium-priority insider buys have outperformed the S&P 500 by a median ~1% over the 30 days after filing — the edge is concentrated in that first month (n ≈ 7,520, 2022-2026). Past results don't predict the future. How we measure this ↗
Director Wendell Amy McBride purchased 1,475 shares of SOLV at $68.03; stock down 21.5% from 52-week high.
Director Wendell Amy McBride purchased 1,475 shares at $68.03, increasing holdings by 41.4% from 3,564 to 5,039 shares. The transaction occurs as SOLV trades 21.5% below its 52-week high of $86.14 and has declined 13.4% over the prior 30 days. McBride's cross-ticker track record shows one prior buy with an average 90-day return of +11.5% and a 100% win rate, though with only one prior comparable transaction this baseline offers limited statistical weight. The company's valuation metrics—P/E of 4.51 and $1.3B in latest quarterly net income against an $11.7B market cap—present relatively compressed multiples in the current market environment.
3M (10% Owner) sold 8,800,000 SOLV shares at $73.45; reduced stake by 25.6% to 25.57M shares
3M executed a substantial open-market sale of 8,800,000 shares (25.6% of holdings) at $73.45 on 2025-08-15, representing $646.4M in transaction value. The sale occurred within the 52-week trading range but in the upper third, with the stock currently trading at $70.76, down 15.8% from its 52-week high of $84.04. This is a material reduction in a 10% stakeholder position—the holder's ownership stake fell from 34.37M shares to 25.57M shares. For context, Solventum's fundamentals show recent revenue of $2.2B with modest annual growth (+0.7%), net income of $90.0M, and a P/E of 32.31; the company commands a $12.3B market cap. The sale's scale and timing relative to the company's current valuation and stock price trend warrant investor attention.
Add SOLV to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.
